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Abstract
Background: Health-related quality of life (HRQL) is poor in obese subjects and is a relevant outcome in
intervention studies. We aimed to determine factors associated with poor HRQL in obese patients seeking weight
loss in medical units, outside specific research projects.
Methods: HRQL, together with a number of demographic and clinical parameters, was studied with generic (SF-36,
PGWB) and disease-specific (ORWELL-97) questionnaires in an unselected sample of 1,886 (1,494 women; 392 men)
obese (BMI > 30 kg/m2) patients aged 20-65 years attending 25 medical units scattered throughout Italy. The
clinics provide weight loss treatment using different programs. General psychopathology (SCL-90 questionnaire),
the presence of binge eating (Binge Eating scale), previous weight cycling and somatic comorbidity (Charlson’s
index) were also determined. Scores on SF-36 and PGWB were compared with Italian population norms, and their
association with putative determinants of HRQL after adjustment for confounders was assessed through logistic
regression analysis.
Results: HRQL scores were significantly lower in women than in men. A greater impairment of quality of life was
observed in relation to increasing BMI class, concurrent psychopathology, associated somatic diseases, binge eating,
and weight cycling. In multivariate analysis, psychopathology (presence of previously-diagnosed mental disorders
and/or elevated scores on SCL-90) was associated with lower HRQL scores on both psychosocial and somatic
domains; somatic diseases and higher BMI, after adjustment for confounders, were associated with impairment of
physical domains, while binge eating and weight cycling appeared to affect psychosocial domains only.
Conclusions: Psychopathological disturbances are the most relevant factors associated with poor HRQL in obese
patients, affecting not only psychosocial, but also physical domains, largely independent of the severity of obesity.
Psychological/psychiatric interventions are essential for a comprehensive treatment of obesity, and to improve
treatment outcome and to reduce the burden of disease.
Introduction
Obesity is associated with impairment of health-related
quality of life (HRQL) in psychological, social, and phy-
sical domains [1,2]. Improvement of HRQL is recog-
nised as a relevant measure of treatment outcome in
obese patients, both in medically- [3,4] and surgically-
treated cases [1,2]. The specific HRQL concepts that
relate to obesity are not clearly defined, although several
aspects of patients’ lives are relevant to obesity [3,4].
Factors reported to be associated with greater impair-
ment of quality of life among treatment seeking obese
patients include female sex [5,6], higher body mass
index [7,8], binge eating disorder [9,10] and psycho-
pathology [9]. They are often associated in the same
individuals. For this reason, the assessment of the rela-
tive contribution of each condition to HRQL can only
be attempted with a large sample size. In particular, the
relative role of somatic diseases, psychological distress
and previous unsuccessful dieting has never been clearly
defined. A few studies found that psychological distress
is also affecting physical domains to a greater extent
than somatic disorders [9]. A correct identification of
factors associated with poor HRQL is essential to
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develop strategies to improve outcome in these patients,
and the association of poor HRQL with depressive
symptoms is the rationale for intensive psychological
support [11].
The QUOVADIS Study [12] is a multicenter, colla-
borative survey designed to assess determinants of qual-
ity of life in treatment-seeking obese patients. The
survey collected a lot of patient-reported data, including
those more frequently associated with poor HRQL [3],
in a large sample of obese subjects seeking weight-redu-
cing programs in 25 medical Italian hospital-based
clinics for the treatment of obesity. Thus, the QUOVA-
DIS database provides a unique opportunity to investi-
gate the factors associated with poor HRQL, to be used
as a guide for treatment outcome [13].
We aimed to identify the factors associated with poor
HRQL in obese subjects, with special reference to the
possible role of psychological distress and psychiatric
comorbidity which might make psychological support
essential to improve treatment outcome.
Sample and methods
Participating subjects with obesity
The philosophy of the QUOVADIS study and the gen-
eral characteristics of the population have been partly
published in a previous report [12]. Briefly, the study
enrolled a representative sample of patients attending
25 hospital-based clinics for weight loss throughout the
country. The centers were both outpatient and inpatient
specialized obesity clinics, providing multidisciplinary
programs for weight loss. The subjects were consecu-
tively enrolled to exclude selection bias. At enrolment,
they were interviewed as to weight history, previous
somatic and mental diseases, hospital admission during
the previous year, self-evaluation of physical activity and
eating pattern, and completed a set of self-administered
questionnaires. In addition, they were submitted to rou-
tine blood tests, but these data were not used in the
present report, specifically based on self-awareness of
previous disorders. We report an analysis based on 1886
subjects whose complete data on the Case Report Form
and on questionnaires were available.
The weight history was checked according to a pre-
defined structured interview [14]. Patients’ answers were
used to compute the total number of dieting programs,
and the total weight loss induced by dieting programs.
The number of dieting attempts was normalized for the
time since first dieting; all other parameters of diet
history were normalized for time since age 20.
To facilitate handling of data, the Case Report Forms
were implemented in an extranet database provided by
CINECA (Casalecchio di Reno, Italy), an Interuniversity
Consortium of 15 Italian Universities, using the AMR
(Advanced Multicenter Research) methodology, which
allows the management of the whole research using
standard web-browsers.
All subjects signed an informed consent to take part in
the study, which was approved by the ethical committees
of the individual centers, after approval by the committee
of the coordinating center (University of Bologna)
Measures
Quality of life was measured using 3 different tools. The
Obesity-Related Well-Being questionnaire (ORWELL-
97), an obesity-specific tool, was used with the specific
aim to collect data useful in a longitudinal evaluation of
HRQL following treatment [15]. It measures the inten-
sity and the subjective relevance of physical and psycho-
logical distress generated by overweight.
A score in the ORWELL-97 questionnaire ≥ 70, corre-
sponding to the 75° percentile of the population, was
considered indicative of a clinically significant burden of
obesity on HRQL.
The Medical Outcome Survey Short-Form 36 (SF-36)
was used as a generic measure of HRQL, with the speci-
fic aim to measure the extent of the defect in HRQL in
both physical and mental domains [16]. The question-
naire is specifically constructed to measure the full
range of health status and well-being by means of
36 multiple-choice questions. It measures 8 different
domains, 4 in the area of physical health (Physical
Functioning, Role Limitation-Physical, Bodily Pain,
General Health) and 4 in the area of mental health
(Role Limitation-Emotional, Vitality, Mental Health, and
Social Functioning). It has been extensively validated
worldwide and Italian normative values have been
defined [17].
The Psychological General Well-Being (PGWB) ques-
tionnaire was used to score psychological distress [18].
The responses to 22 questions are arranged in 6 affec-
tive states: anxiety, depressed mood, positive well-being
self-control, general health and vitality. The Italian ver-
sion of the questionnaire has been recently validated
and normative values are available to compare the
results with population standards [19].
For both SF-36 and PGWB, the values of individual
domains of each patient were compared to the age- and
sex-matched Italian population norms [17,19] using the
Z-score (difference between patient value and control
mean, divided by control standard deviation). According
to Cohen [20], the average Z-scores (effect sizes) were
rated as small (between 0.20 and 0.50), as moderate
(between 0.50 and 0.80) or as large (> 0.80). This propo-
sal is supported by clinical studies [21].
The Binge Eating Scale was used to detect binging
[22]; values in the range 17-26 were considered suspect
of binge eating, whereas values ≥ 27 were taken as pre-
dictive of Binge Eating Disorder. This classification was
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used to score binge eating on a scale from 0 (< 17) to 2
(≥ 27).
The Symptom Check List-90 questionnaire was used
to identify subjects with a psychopathological profile
[23]. A value ≥ 1 in the Global Severity Index (GSI) is
suggestive of psychopathology, scored as mild (1.00 -
1.49), moderate (1.50 - 1.99), or severe (≥ 2.00). These
results of SCL-90 were combined with clinical data to
score the presence of mental disorder on a scale from 0
to 5. A previous diagnosis of psychopathological pro-
blems was valued 2 points, GSI values in the range 1.00-
1.49 (mild distress) were given a score of 1, values
between 1.50 and 1.99 (moderate distress) were given a
score of 2, values ≥ 2.00 (severe distress) were given a
score of 3.
The presence of somatic diseases was used to calculate
a composite score, according to Charlson et al [24], with
modifications. For this purpose, one point was added for
the reported presence of any of the following states: dia-
betes, hypertension, other endocrine disorders, liver or
biliary disease, hip or knee pain. The presence of cardio-
vascular disease (any condition, including angina, pre-
vious myocardial infarction or stroke, peripheral or
carotid vascular disease) and a previous diagnosis of
cancer were given 2 points.
Weight history was defined at interview on the basis
of body weight at the age of 20 years, age at first dieting
and the number of times patients had lost weight as an
effect of dietary programs, and scored according to pre-
viously-published cut-offs [14]. One point was assigned
for any value exceeding the 75° percentile in 3 items
reflecting weight history: a) number of dieting attempts
(cut-off, 0.56/year); b) weight gain since age 20 years
(cut-off, 1.87 kg/year); c) cumulative weight loss (cut-off,
2.63 kg/year).
Statistical analysis
A first descriptive analysis was carried out on all tested
variables. Scores of HRQL (and their relative Z-scores)
were grouped according to sex, age, clinical status, com-
plications of disease and eating behavior disorders, and
the means and 95% confidence intervals for each patient
group and for each domain were calculated.
Differences between obese classes were tested using
unpaired t test or Mann-Whitney or Kruskall-Wallis
test, due to non-gaussian distribution of data, as appro-
priate. Differences in the prevalence of categorical data
were tested by R × C c2 test.
Multivariate logistic regression analyses were run
using dichotomized Z-scores on individual domains of
SF-36 and PGWB as dependent variables. The cut-off
value vas set at -1.0, but a sensitivity analysis, using the
cut-offs of -0.5 and -1.5 was also performed, and the
results were qualitatively confirmed (not reported in
details). In the ORWELL-97 model, the dependent vari-
able was an ORWELL score >70. Independent variables
were BMI classes, the scores of somatic and mental dis-
eases, the BES grade, and the score of weight history.
All models were adjusted for age, gender and BMI.
The Variance Inflation Factor was calculated to assess
correlation between independent variables and to
exclude multicolinearity.
Results
Clinical and psychological characteristics of the study
sample
Of the 1,886 patients (1,494 women and 392 men)
included in the analysis, 723, 529, and 634 had obesity
class I, II and III, respectively. Their age ranged from 20
to 65 years (Class I, 45.4 ± SD 11.3 years; Class II,
44.8 ± 10.7; Class III, 43.9 ± 10.9; P = 0.049, Kruskall-
Wallis test). Subjects in Class I were characterized by a
higher educational status (primary school 16%, degree
10%) compared with Class II (16% and 9%, respectively)
and Class III (21% and 5%, respectively; P < 0.0001). No
differences were observed in civil status (single/divorced
vs. married/cohabitating or widowed). A larger propor-
tion of subjects in Class III were either housewives
(26%) or unemployed (4.4%) compared with Class II
(19 and 3.5%) or Class I (17 and 2.8%, respectively;
P < 0.0001). Patients in higher classes of obesity showed
a significantly greater prevalence of several concurrent
illnesses, such as diabetes, hypertension, biliary diseases,
and osteoarticular problems, but not of hyperlipidemia,
coronary heart and peripheral vascular disease, thyroid
disorders, or previously diagnosed psychopathological
distress (Table 1).
The large majority of subjects reported previous
attempts to lose weight (Table 2). Patients with higher
BMI reported earlier age of first dieting, greater BMI at
age 20 years, higher maximum weight loss obtained in
the past, and higher cumulative weight loss per year.
Scores on the Binge Eating Scale (BES) were in a range
suggestive of binge eating in over one fourth of subjects,
while over 10% of patients had BES scores indicative of
binge eating disorder. Mean BES scores were signifi-
cantly higher in patients with class III obesity when
compared with the rest of the sample. Similarly, psycho-
pathological distress (Symptom CheckList-90) was more
frequent and more severe with progressive obesity class.
Health-related quality of life
HRQL was progressively impaired with increasing BMI.
This was shown by all three HRQL measures, i.e., both
by the specific ORWELL-97 questionnaire and by the
generic SF-36 and PGWB instruments (Table 3).
Although all domains were affected, the greatest
decrease was observed in domains reflecting physical
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status, with a less significant impairment in mental
health.
The Z-scores on SF-36 domains, reflecting the impair-
ment of HRQL in comparison with sex- and age-specific
population norms, showed that HRQL was particularly
poor in the domain of Physical Functioning (-1.33), all
other domains being in the moderate range (Role-Physi-
cal, -0.67; General Health, -0.61; Vitality, -0.61; Social
Functioning, -0.57; Bodily Pain, -0.54) or in the small
range (Role-Emotional, -0.47; Mental Health, -0.30). The
Z-scores on all domains of PGWB, except Vitality
(-0.51), were indicative of a small defect (Anxiety, -0.27;
Depression, -0.30; Well-Being, -0.35; Self-Control, -0.41;
General Health, -0.44).
SF-36 and PGWB Z-scores in women and men are
summarized in Figure 1. There was a systematic trend
towards lower Z-scores in females (by 0.1 - 0.2 points),
with the notable exception of Physical Functioning,
which was significantly lower in males (-1.49 vs. -1.29 in
females; P = 0.025). The difference between males and
Table 1 Prevalence of physical problems, as reported by patients entering a weight-reducing program (prevalence
and 95% CI)
Clinical data Class I Obesity
BMI, 30-34.9 kg/m2
n = 723
Class II Obesity
BMI, 35-39.9 kg/m2
n = 529
Class III Obesity
BMI, ≥40 kg/m2
n = 634
P*
Diabetes 5.5 (4.0 - 7.4) 8.2 (6.1 - 10.8) 14.4 (11.8 - 17.3) < 0.001
Hypertension 25.9 (22.8 - 29.2) 38.6 (34.4 - 42.7) 46.9 (43.0 - 50.7) < 0.001
Hyperlipidemia 24.0 (21.0 - 27.2) 22.5 (19.0 - 26.1) 21.4 (18.3 - 24.6) 0.506
Coronary heart disease 2.2 (1.3 - 3.5) 3.2 (1.9 - 4.9) 2.5 (1.5 - 4.0) 0.556
Myocardial infarction 1.5 (0.8 - 2.6) 1.3 (0.6 - 2.6) 1.3 (0.6 - 2.4) 0.916
Peripheral vascular dis. 0.0 (0.0 - 0.4) 0.9 (0.3 - 2.0) 0.2 (0.0 - 0.8) 0.530
Gallstones 10.3 (8.3 - 12.7) 13.3 (10.6 - 16.3) 18.0 (15.2 - 21.1) < 0.001
Cholecystectomy 6.6 (5.0 - 8.6) 8.1 (6.0 - 10.6) 11.6 (9.3 - 14.3) 0.004
Hip pain 27.5 (24.3 - 30.7) 30.7 (26.9 - 34.6) 35.0 (31.3 - 38.7) 0.011
Knee pain 35.9 (32.4 - 39.4) 38.4 (34.3 - 42.5) 47.9 (44.0 - 51.8) < 0.001
Other endocrine diseases 14.1 (11.7 - 16.7) 17.4 (14.3 - 20.8) 15.5 (12.8 - 18.5) 0.268
Previous cancer 7.2 (5.5 - 9.2) 8.6 (6.5 - 11.2) 5.7 (4.1 - 7.7) 0.152
Psychological distress 17.2 (14.6 - 20.1) 18.3 (15.2 - 21.8) 19.0 (16.1 - 22.2) 0.699
Data are presented as prevalence and 95% CI.
*Chi2 test.
Table 2 Weight history, scores on the Binge Eating Scale and Symptom CheckList-90 by obesity classes
Class I Obesity†
n = 723
Class II Obesity
n = 529
Class III Obesity
n = 634
P
value
Weight history variables
BMI at age 20 (kg/m2) 23.8 ± 3.4 25.7 ± 4.6 28.3 ± 6.1 < 0.001*
Extra weight since age 20 (kg/year) 1.1 ± 0.8 1.4 ± 0.9 2.2 ± 1.7 < 0.001*
No. of previous dieting (per year) 0.20 (0 - 2.6) 0.21 (0 - 4.0) 0.27 (0 - 2.5) < 0.001*
Age at first dieting (years) 29.6 ± 11.7 27.1 ± 11.2 25.4 ± 10.4 < 0.001*
Maximum weight loss (kg) 13.0 ± 8.4 15.9 ± 9.1 21.1 ± 11.5 < 0.001*
Cumulative weight loss (kg/year) 1.4 ± 1.9 1.9 ± 2.4 2.7 ± 3.1 < 0.001*
Binge Eating Scale
Score 12.9 ± 9.0 15.0 ± 9.5 16.8 ± 9.5 < 0.001*
Score in the range 17 - 26 (%) 24 (20 - 26) 27 (24 - 31) 29 (25 - 32) 0.064°
Score > 26 (%) 11 (9 - 13) 13 (11 - 16) 15 (13 - 18) 0.042°
Symptom CheckList-90
Global Severity Index 0.70 ± 0.53 0.79 ± 0.57 0.90 ± 0.62 < 0.001*
Mild distress (%) 15 (13 - 18) 14 (12 - 18) 20 (17 - 23) 0.016°
Moderate distress (%) 5 (3 - 6) 9 (7 - 12) 10 (7 - 12) 0.001°
Severe distress (%) 3 (2 - 5) 4 (3 - 6) 6 (5 - 8) 0.024°
Data are presented as mean ± SD, median and range, or as prevalence (95% confidence interval) of cases exceeding selected cut - offs.
† For ranges of obesity classes, see Table 1.
*Kruskall-Wallis or °chi2 test
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females was particularly significant in PGWB domains
(P < 0.001 for Depression, Self-control, Well-being and
General health; < 0.05 for Anxiety; Mann-Whitney
U test). Depression was not different from population
norm in males.
Z-scores on SF-36 and PGWB in relation to obesity
class are summarized in Figure 2. A systematic trend
towards more severe impairment with increasing BMI
(P < 0.001 was observed for all domains, except Anxiety
at PGWB, P = 0.0024).
Factors associated with poor HRQL
Logistic regression analysis was applied to identify fac-
tors associated with poor HRQL (Table 4). For both
genders, the most significant factor was the presence of
mental disease, as assessed by the composite score
including both a reported previous history of psycholo-
gical distress and a score at SCL-90 above the prede-
fined cut-offs. This score was predictive of poor
HROQL both in domains more closely associated with
mental state and in those reflecting physical functioning.
Data were confirmed by correlation analysis; the r coef-
ficient of correlation between SCL-90 and individual Z-
scores varied between -0.672 for Depressed mood in
PGWB and -0.300 for Physical functioning in SF-36.
Conversely, somatic disease, as expressed by the compo-
site index, was associated with lower scores on the phy-
sical domains of SF-36, but had little impact on
psychological domains, with the notable exception of
social functioning. Among PGWB scales, only General
Health appeared to be affected by somatic comorbidities
in a relevant manner. No significant association of
somatic index with ORWELL scores was observed, after
adjustment for potential confounders.
BMI class was systematically associated with poor
HRQL in the ORWELL-97 score and in the physical
domains of SF-36, namely in Physical functioning, but it
had almost no effect on PGWB domains with the excep-
tion of General health. This association was confirmed
at multivariate analysis, after adjustment for concurrent
somatic and psychiatric diseases. In correlation analysis,
the highest value was observed between BMI and the
Z-score of Physical functioning (r = -0.405).
A BES score above the selected cut-offs was associated
with poor HRQL in nearly all domains of HRQL mea-
sures, whereas a history of weight cycling was associated
with poor HRQL only in a few domains of SF-36,
namely in Role-Physical, General Health and Social
Functioning.
In all models the Variance Inflation Factor was < 5,
indicating the absence of multicolinearity.
Discussion
In our study sample, obesity was associated with a rele-
vant impairment of HRQL, in comparison with popula-
tion norms, standardized for age and sex. This result is in
keeping with previous reports of overweight-induced
deterioration of HRQL across a wide age range [7,25-27].
Table 3 Scores of health-related quality of life in the QUOVADIS population
Class I Obesity†
n = 723
Class II Obesity
n = 529
Class III Obesity
n = 634
P*
ORWELL-97 41.3 ± 25.7 50.0 ± 28.3 58.5 ± 29.4 < 0.001
Short Form-36
Physical Functioning 76.8 ± 19.5 70.5 ± 21.5 57.1 ± 24.4 < 0.001
Role physical 68.6 ± 35.6 60.3 ± 39.4 51.4 ± 39.9 < 0.001
Bodily pain 64.7 ± 26.7 61.7 ± 27.7 52.8 ± 27.9 < 0.001
General health 61.1 ± 20.9 57.8 ± 20.5 50.3 ± 21.6 < 0.001
Vitality 53.4 ± 19.7 51.2 ± 20.4 47.2 ± 22.0 < 0.001
Role Emotional 65.0 ± 38.5 59.8 ± 39.7 56.4 ± 40.2 < 0.001
Mental health 61.2 ± 21.2 60.8 ± 20.6 58.9 ± 21.1 < 0.001
Social functioning 69.4 ± 24.8 65.5 ± 25.2 61.6 ± 26.9 < 0.001
Psychological General Well-Being
Depressed mood 11.9 ± 2.6 11.5 ± 2.7 11.0 ± 3.2 0.002
Anxiety 15.9 ± 4.9 15.4 ± 5.1 14.9 ± 5.3 < 0.001
Positive well-being 10.6 ± 3.8 10.2 ± 3.9 9.6 ± 4.0 < 0.001
Self-control 11.1 ± 3.1 10.7 ± 3.2 10.3 ± 3.5 < 0.001
General health 10.5 ± 2.7 9.9 ± 2.8 8.9 ± 2.9 < 0.001
Vitality 11.8 ± 3.9 11.3 ± 4.0 10.5 ± 4.0 < 0.001
Global index 71.8 ± 17.3 68.9 ± 18.3 65.3 ± 19.6 < 0.001
Data are reported as means ± SD.
† For ranges of obesity classes, see Table 1.
* Kruskall-Wallis test
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The study sample was entirely composed of obese
patients seeking medical treatment for weight loss and
cannot be considered representative of the general popu-
lation of obese subjects. In this respect, poor HRQL
could be a motivation for referral and poorer scores are
usually observed in clinic-based samples when compared
with population-based surveys [27]. On the other hand,
the study of these patients could provide a more accurate
picture of obese individuals referring to specialized meta-
bolic clinics, and provide relevant clues for treatment
programs.
The study has several strengths. It was based on a very
large sample of obese men and women in different centers,
thus being representative of the “real world” of treatment-
seeking obesity, outside specific research centers where a
selection bias may be expected. As expected, obese
women experienced a greater impairment of HRQL than
their male counterparts. This confirms previous reports in
clinic-based samples [6,15,25], among patients with
chronic illness [5], and in population studies [28]. Gender
differences in HRQL could be related to the higher preva-
lence of psychopathology among women [15,25,29], or to
a greater cultural drive for thinness experienced by the
female sex in Western societies [30].
Not surprisingly, subjects with higher BMI reported a
greater impairment of HRQL, as previously reported
[7,8]. This phenomenon can be partly due to the higher
prevalence of concurrent somatic diseases and psycho-
pathological disturbances in morbidly obese patients,
when compared to individuals with lesser degrees of obe-
sity. However, a greater impairment of HRQL in those
with higher BMI persisted at multivariate analysis even
after adjustment for somatic diseases, mental disorders,
binge eating and weight cycling. A higher BMI appeared
to affect mainly physical, rather than psychosocial, com-
ponents of HRQL, suggesting that the functional impair-
ment and physical discomfort determined by extreme
overweight can have a major role in poor HRQL.
Figure 1 Z-scores on Short Form-36 (upper panel) and
Psychological General Well-being questionnaires in relation to
gender (Females, open circles; Males, closed circles). Data are
presented as means and 95% confidence intervals. All domains
crossing the zero line are not significantly different from population
norm. Legend for SF-36: PF, Physical Functioning; RP, Role limitation
- Physical; BP, Bodily Pain; GH, General Health; VT, Vitality; MH,
Mental Health; RE, Role limitation - Emotional; SF, Social Functioning.
Legend for PGWB: AX, Anxiety; DP, Depression; WB, Well-Being; SC,
Self-Control; GH, General Health; VT, Vitality.
Figure 2 Z-scores on Short Form-36 (upper panel) and
Psychological General Well-being questionnaires in relation to
obesity class (Class I (BMI, 30-34.9 kg/m2), open circles; Class II
(BMI, 35-39.9), closed circles; Class III (BMI, ≥40), open squares).
Data are presented as means and 95% confidence intervals. Legend:
for abbreviations, see Figure 1
Mannucci et al. Health and Quality of Life Outcomes 2010, 8:90
http://www.hqlo.com/content/8/1/90
Page 6 of 9
Somatic comorbidities, assessed through a score
derived from Charlson’s index [24], were associated with
poorer scores on physical domains of HRQL instru-
ments, but had little effect, after adjustment for con-
founders, on psychosocial domains. Concurrent somatic
diseases also had a small impact on scores of the
ORWELL-97 questionnaire, confirming its validity for
obesity-related quality of life [15]. Conversely, psycho-
pathological disturbances were associated with impair-
ment of both physical and psychosocial domains of
quality of life, even after adjustment for confounders.
The presence of depressed mood and/or high levels of
anxiety, which are the most common psychological dis-
turbances observed in clinical samples of obese patients
[31], can increase subjective distress induced by disease-
related physical symptoms and functional impairment
[15]. In the present sample, psychopathology was the
most important predictor of quality of life among obese
patients, in both psychosocial and physical domains.
This result is partly in contrast with a previous survey
in a small sample of obese patients undergoing bariatric
surgery, where mental disorders appeared to affect psy-
chosocial, but not physical domains of SF-36 [32]. Con-
flicting results can be attributed to differences in sample
size (the previous sample being 18 times smaller than
the one described in this study) or type of referral (sur-
gery in the previous report vs. medical weight loss pro-
grams in the majority of centers of the present survey).
In addition, the present study included obese subjects
belonging to the whole spectrum of obesity classes,
including a large group of subjects with obesity class III.
These individuals are scarcely represented in medical
settings, and may have a different psychopathological
profile [33]. Finally, the definition of psychological dis-
turbances in our study included not only a formal diag-
nosis of mental disorders, but also high scores on a
questionnaire for general psychopathology, which could
provide a more accurate description of the psychological
status of patients at the time of HRQL assessment.
Binge eating disorder was previously reported to be
associated with poor scores on disease-specific HRQL
questionnaires [10,15]. This is consistent with the find-
ing of a poorer perceived health status in patients with
higher scores on the Binge Eating Scale. The association
of binge eating with impaired HRQL can be partly
mediated by higher BMI [34], a greater prevalence of
mental disorders [31,34] and more frequent weight
cycling in these cases. After adjustment for these poten-
tial confounders, binge eating was only marginally asso-
ciated with some, but not all psychological domains of
HRQL, without any impact on physical scales.
Finally, weight cycling is known to be associated with
binge eating [34] and psychopathology [14], and with
higher long-term morbidity and mortality [35-37], but
its relationship with HRQL has never been demon-
strated. In the present study, weight cycling was only
associated with a few domains of quality of life, after
adjustment for BMI class, somatic diseases, binge eating
Table 4 Association of clinical parameters with poor health-related quality of life
% +ve BMI Class Somatic disease Mental disease Binge eating Weight history
ORWELL-97 24.8° 1.35 (1.03-1.75)† 1.17 (1.07-1.29)* 1.96 (1.74-2.21)* 1.64 (1.39-1.93)* ———
Short Form-36
Physical functioning 48.8 1.29 (1.00-1.66)† 1.22 (1.12-1.33)* 1.32 (1.18-1.47)* ——— ———
Role-Physical 36.7 1.38 (1.09-1.75)† 1.25 (1.14-1.36)* 1.54 (1.38-1.72)* 1.28 (1.10-1.49)† 1.20 (1.04-1.38)†
Bodily pain 38.3° ——— 1.31 (1.20-1.43)* 1.47 (1.32-1.64)* 1.18 (1.01-1.36)† ———
General health 36.2° ——— 1.36 (1.25-1.48)* 1.54 (1.37-1.72)* 1.29 (1.11-1.50)* 1.19 (1.04-1.37)†
Vitality 35.7° ——— 1.17 (1.08-1.28)* 1.89 (1.69-2.12)* 1.32 (1.14-1.54)* ———
Role-Emotional 36.5° ——— 1.18 (1.08-1.28)* 1.89 (1.69-2.12)* 1.45 (1.25-1.69)* ———
Mental health 25.4 1.34 (1.03-1.74)† 1.20 (1.09-1.32)* 1.98 (1.76-2.22)* 1.29 (1.10-1.52)* ———
Social functioning 37.8° 1.32 (1.04-1.68)† 1.15 (1.05-1.25)† 2.03 (1.80-2.28)* 1.33 (1.14-1.54)* 1.16 (1.01-1.32)†
Psychological General Well-Being
Depressed mood 21.9 ——— ——— 2.12 (1.88-2.40)* 1.56 (1.31-1.84)* ———
Anxiety 23.7 1.35 (1.02-1.76)† 1.17 (1.06-1.29)† 2.10 (1.86-2.36)* 1.32 (1.12-1.56)† ———
Well-being 24.9 1.62 (1.25-2.11)* 1.13 (1.03-1.24)† 2.00 (1.78-2.25)* 1.35 (1.15-1.58)* ———
Self-control 27.8° ——— ——— 2.05 (1.83-2.31)* 1.58 (1.35-1.85)* ———
General health 28.4° 1.52 (1.18-1.94)* 1.30 (1.19-1.43)* 1.67 (1.49-1.87)* 1.46 (1.25-1.70)* ———
Vitality 31.3 ——— 1.21 (1.11-1.32)* 1.95 (1.73-2.18)* 1.43 (1.23-1.67)* ———
A score of ORWELL-97 above the 75° percentile or a Z-score of individual domains of SF-36 and PGWB lower than -1.0 were the dependent variables. Data are
presented as odds ratio (95% confidence intervals) for any 1-point increase in BMI class and in the scores of somatic and mental disease, binge eating and
weight history (see Materials & Methods for calculations). All data are adjusted for age, gender and BMI.
°Significantly higher in females than in males (P < 0.05).
*P < 0.001; † P < 0.05 for the significance of association.
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and psychopathology. It can be speculated that previous
unsuccessful attempts at losing weight can negatively
affect patients’ confidence in the possibility to treat obe-
sity effectively, thus making the psychological burden
heavier and heavier. Accordingly, physicians should
carefully test patients’ motivation at entry into weight
loss programs, considering that any treatment failure
may be accompanied by a further deterioration of their
HRQL. A definition of weight loss expectation and rea-
listic treatment outcomes is pivotal to reduce the bur-
den of disease associated with treatment failure [38].
The broad spectrum of questionnaires used in the
study may also help identify which instruments should
be preferred to detect impairment in HRQL in different
settings. It is noteworthy that scores on both generic
(SF-36, PGWB) and disease-specific (ORWELL-97)
questionnaires appeared to be affected by the very same
factors and in a similar manner. As expected, PGWB
appeared to be more sensitive to psychological distur-
bances, while SF-36 and ORWELL-97 could detect to a
greater extent the impact of physical conditions on
HRQL. The choice of questionnaires in different settings
should take into consideration the domains of greater
interest (physical vs. psychological) in individual studies.
The choice of instruments for the assessment of the
effects of treatment on HRQL should also consider
reliability, which is assumed to be greater for generic
questionnaires, and sensitivity to change, which is
thought to be superior for disease-specific question-
naires; these characteristics were not assessed in the
present study.
Conclusion
Our study has relevant clues to obesity treatment.
HRQL is now considered a priority in the treatment of
chronic diseases, and may be selected as clinical-relevant
outcome in treatment programs [39]. The finding that
psychopathological distress is the main determinant of
poor HRQL makes psychiatric and psychological sup-
port essential in obesity centers. Only a multidisciplinary
approach in weight management programs, addressing
both mental and somatic disorders, is likely to reduce
the burden of obesity in individual patients.
Note
A complete list of the participants in the QUOVADIS
study has been previously published (Diab Nutr Metab
2003, 16:115-124).
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